SUCCINYLCHOLINE CHLORIDE
| Brand name | SUCCINYLCHOLINE CHLORIDE |
|---|---|
| Active ingredient | SUCCINYLCHOLINE CHLORIDE |
| Strength | 100MG/5ML (20MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR, INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | August 2021 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 12295932 | November 2041 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.